-
Doctors Urge Need for ‘Common Sense Oncology’
A movement of health care professionals say the toll of many cancer treatments is out of sync with the purported benefits.
by Kyle Bagenstose
-
2023: The Year in Cancer News
The Cancer Today editors share the most impactful reporting and essays of 2023.
by Cancer Today staff
-
Emerging Treatments for Brain Metastases in Breast Cancer
SABCS panel describes advances and pivotal questions in managing patients whose breast cancer has metastasized to their brain.
by Marci A. Landsmann
-
Cancer Today Editors’ Picks: 2023
The editors of Cancer Today share the stories that most resonated with readers in 2023.
-
Patient Advocates as Research Partners
Speakers at SABCS discuss how people who have lived with breast cancer can be valuable partners in research.
by Eric Fitzsimmons
-
Understanding Side Effects and the Patient Experience
Researchers focus on assessing quality of life and toxicity risks in people with breast cancer.
by Thomas Celona
-
Addressing Social Determinants of Health
Speakers at SABCS discuss measuring and meeting social factors that affect the health and outcomes of breast cancer patients.
by Kevin McLaughlin
-
Exercise Benefits in Metastatic Breast Cancer
Study finds supervised physical activity can help improve quality of life and reduce fatigue among people with metastatic breast cancer.
by Thomas Celona
-
Finding Answers in Prostate Cancer
PSMA PET imaging is helping clinicians more accurately stage prostate cancer and provide precision treatment.
by Sandra Gordon
-
Is Chemo-free Treatment Coming for HER2-positive Breast Cancer?
Evidence grows that some people with HER2-positive breast cancer may do well on HER2-targeted therapy alone.
by Myles Starr
Cancer Talk
Living With Your Loved One’s Prostate Cancer
Christine Ledbetter on the ways her husband’s prostate cancer affected their relationship and finding support as a caregiver.
by Christine Ledbetter
Continuing the ConversationThe AACR hosts a roundtable to ‘get real’ about cancer health disparities.
by Marci A. Landsmann
More Patients Participating in Cancer ResearchA higher proportion of cancer patients are enrolling in research studies than previously thought, but many patients lack the access needed to participate.
by Kyle Bagenstose
Immunotherapy Drug Tarlatamab Approved for Advanced Small Cell Lung CancerThe drug showed promise in treating small cell lung cancer that had progressed during or after chemotherapy.
by Laura Gesualdi-Gilmore